Can Trintellix (vortioxetine) and Klonopin (clonazepam) be used together?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

I strongly advise against using Trintellix (vortioxetine) and Klonopin (clonazepam) together without proper medical supervision, as this combination can increase the risk of adverse effects such as drowsiness, dizziness, and cognitive impairment, as well as potentially life-threatening serotonin syndrome 1. When considering the use of Trintellix and Klonopin together, it is essential to weigh the potential benefits against the risks. Trintellix is an antidepressant that affects serotonin levels, while Klonopin is a benzodiazepine used for anxiety and seizure disorders. The combination of these medications can increase the risk of adverse effects, particularly serotonin syndrome, which can be triggered by elevated brain serotonin levels 1.

Key Considerations

  • The dosing, timing, and appropriateness of this combination depend on individual medical conditions, other medications being taken, and individual response to each drug.
  • Close monitoring for adverse effects, particularly suicidality, is recommended when using SSRIs, including Trintellix, especially in the first months of treatment and following dosage adjustments 1.
  • Behavioral activation/agitation, mania/hypomania, and sexual dysfunction are potential side effects of SSRIs, including Trintellix, and should be closely monitored 1.
  • The potential for serotonin syndrome, a potentially life-threatening condition, should be carefully considered when combining serotonergic medications, including Trintellix and other medications that affect serotonin levels 1.

Recommendations

  • If considering the use of Trintellix and Klonopin together, consult with a healthcare provider to evaluate individual medical history and monitor for adverse effects.
  • Never adjust medication regimens on your own, as stopping either medication abruptly can lead to withdrawal symptoms or worsening of the condition.
  • Carefully weigh the potential benefits and risks of using Trintellix and Klonopin together, and consider alternative treatment options that may be safer and more effective.

From the Research

Trintellix and Klonopin Usage

  • There are no direct studies on the combined use of Trintellix (vortioxetine) and Klonopin (clonazepam) in the provided evidence.
  • However, the studies suggest that vortioxetine is a generally efficacious and well-tolerated antidepressant agent, approved for the treatment of major depressive disorder (MDD) in adults 2, 3.
  • Vortioxetine has a distinctive pharmacological profile, combining inhibition of the serotonin transporter with modulation of multiple serotonin receptors, and has been shown to enhance cognitive performance in various animal models and clinical trials 2, 3.
  • The drug has also been found to be effective in treating anxiety disorders, including generalized anxiety disorder (GAD) 4, 5.
  • In terms of safety and tolerability, vortioxetine has been shown to have a fairly benign profile, with common side effects including nausea, vomiting, diarrhea, and dry mouth 5.
  • While there is no direct evidence on the use of Trintellix and Klonopin together, the studies suggest that vortioxetine can be used as a switch therapy in patients with MDD who have not responded to or tolerated other antidepressant therapies, including SSRIs and SNRIs 6.
  • It is essential to consult with a healthcare professional before taking any medication, especially when combining different drugs, to discuss potential interactions and side effects.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Comparative evaluation of vortioxetine as a switch therapy in patients with major depressive disorder.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.